Global Clinical Bronchiolitis Obliterans Trials Review, 2014

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

Summary

GlobalData's clinical trial report, Bronchiolitis Obliterans Global Clinical Trials Review, H2, 2014" provides data on the Bronchiolitis Obliterans clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bronchiolitis Obliterans.

To Browse a Full Report with Toc: http://www.researchmoz.us/bronchiolitis-obliterans-global-clinical-trials-review-h2-2014-report.html

It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bronchiolitis Obliterans. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Bronchiolitis Obliterans 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12

List of Tables
Bronchiolitis Obliterans Therapeutics, Global, Clinical Trials by Region, 2014* 7
Bronchiolitis Obliterans Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bronchiolitis Obliterans Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bronchiolitis Obliterans Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Bronchiolitis Obliterans Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Bronchiolitis Obliterans Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Bronchiolitis Obliterans Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Bronchiolitis Obliterans to Respiratory Clinical Trials, G7 Countries (%), 2014* 14

To Browse a Full Report with Toc: http://www.researchmoz.us/bronchiolitis-obliterans-global-clinical-trials-review-h2-2014-report.html  

All Reports of this Category Here: http://www.researchmoz.us/pharmaceutical-market-reports-38.html
 
About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Contact US:


For More Information Kindly Contact:
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://mresearchreports.blogspot.com/
Get More Market Research Report : https://www.linkedin.com/today/author/355409463

Global Clinical Chronic Asthma Trials Review, 2014

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

Summary

GlobalData's clinical trial report, Chronic Asthma Global Clinical Trials Review, H2, 2014" provides data on the Chronic Asthma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Asthma.

To Browse a Full Report with Toc: http://www.researchmoz.us/chronic-asthma-global-clinical-trials-review-h2-2014-report.html

It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Asthma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Chronic Asthma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Chronic Asthma to Respiratory Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17

List of Tables
Chronic Asthma Therapeutics, Global, Clinical Trials by Region, 2014* 7
Chronic Asthma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Chronic Asthma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Chronic Asthma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Chronic Asthma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Chronic Asthma Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Chronic Asthma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Chronic Asthma Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14

To Browse a Full Report with Toc: http://www.researchmoz.us/chronic-asthma-global-clinical-trials-review-h2-2014-report.html

All Reports of this Category Here: http://www.researchmoz.us/pharmaceutical-market-reports-38.html


About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Contact US:


For More Information Kindly Contact:
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://mresearchreports.blogspot.com/
Get More Market Research Report : https://www.linkedin.com/today/author/355409463

Global Clinical Chronic Bronchitis Trials Review, 2014

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

Summary

GlobalData's clinical trial report, Chronic Bronchitis Global Clinical Trials Review, H2, 2014" provides data on the Chronic Bronchitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Bronchitis.

To Browse a Full Report with Toc: http://www.researchmoz.us/chronic-bronchitis-global-clinical-trials-review-h2-2014-report.html

It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Bronchitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Chronic Bronchitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8

List of Tables
Chronic Bronchitis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Chronic Bronchitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Chronic Bronchitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Chronic Bronchitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Chronic Bronchitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Chronic Bronchitis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Chronic Bronchitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Chronic Bronchitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Chronic Bronchitis to Respiratory Clinical Trials, G7 Countries (%), 2014* 15
Chronic Bronchitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Chronic Bronchitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Chronic Bronchitis to Respiratory Clinical Trials, E7 Countries (%), 2014* 18

To Browse a Full Report with Toc: http://www.researchmoz.us/chronic-bronchitis-global-clinical-trials-review-h2-2014-report.html

All Reports of this Category Here: http://www.researchmoz.us/pharmaceutical-market-reports-38.html


About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Contact US:


For More Information Kindly Contact:
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://mresearchreports.blogspot.com/
Get More Market Research Report : https://www.linkedin.com/today/author/355409463

Global Clinical Empyema Trials Review, to 2014

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

Summary

GlobalData's clinical trial report, Empyema Global Clinical Trials Review, H2, 2014" provides data on the Empyema clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Empyema. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.

To Browse a Full Report with Toc: http://www.researchmoz.us/empyema-global-clinical-trials-review-h2-2014-report.html

The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Empyema. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Empyema 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11

List of Tables
Empyema Therapeutics, Global, Clinical Trials by Region, 2014* 6
Empyema Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Empyema Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Empyema Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Empyema Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Empyema Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Empyema to Respiratory Clinical Trials, G7 Countries (%), 2014* 12
Empyema Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Empyema Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Empyema Therapeutics, Global, Clinical Trials by Phase, 2014* 15
Empyema Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 16
Empyema Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17

To Browse a Full Report with Toc: http://www.researchmoz.us/empyema-global-clinical-trials-review-h2-2014-report.html

All Reports of this Category Here: http://www.researchmoz.us/pharmaceutical-market-reports-38.html

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Contact US:


For More Information Kindly Contact:
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://mresearchreports.blogspot.com/
Get More Market Research Report : https://www.linkedin.com/today/author/355409463

Global Clinical Influenza A and B Infections Trials Review, 2014

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

Summary

GlobalData's clinical trial report, Influenza A and B Infections Global Clinical Trials Review, H2, 2014" provides data on the Influenza A and B Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Influenza A and B Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.

To Browse a Full Report with Toc: http://www.researchmoz.us/influenza-a-and-b-infections-global-clinical-trials-review-h2-2014-report.html

The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Influenza A and B Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Influenza A and B Infections 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Influenza A and B Infections to Infectious Disease Clinical Trials 15

List of Tables
Influenza A and B Infections Therapeutics, Global, Clinical Trials by Region, 2014* 7
Influenza A and B Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Influenza A and B Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Influenza A and B Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Influenza A and B Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Influenza A and B Infections Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Influenza A and B Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Influenza A and B Infections Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Influenza A and B Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Influenza A and B Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Influenza A and B Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Influenza A and B Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18

To Browse a Full Report with Toc: http://www.researchmoz.us/influenza-a-and-b-infections-global-clinical-trials-review-h2-2014-report.html

All Reports of this Category Here: http://www.researchmoz.us/pharmaceutical-market-reports-38.html

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Contact US:


For More Information Kindly Contact:
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://mresearchreports.blogspot.com/
Get More Market Research Report : https://www.linkedin.com/today/author/355409463

Global Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

Summary

GlobalData has released its new PharmaPoint Drug Evaluation report, Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus represents a huge burden on healthcare systems.

To Browse a Full Report with Toc: http://www.researchmoz.us/cyramza-colorectal-cancer-forecast-and-market-analysis-to-2023-report.html

This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the colorectal cancer market, with coverage of multiple settings of the disease including neoadjuvant/adjuvant, first-, second-, third-line KRAS wild-type and mutation-positive, and fourth-line metastatic. In terms of targeted treatments, the metastatic CRC treatment landscape is mature, including the branded treatments Avastin (bevacizumab), Erbitux (cetuximab), and Vectibix (panitumumab), treatments that have extended the survival of metastatic patients compared to chemotherapy-only regimens. However, high unmet needs remain for the extension of survival of metastatic patients, and particularly those with KRAS mutation-positive disease, for whom the epidermal growth factor receptor (EGFR) inhibitors Erbitux and Vectibix are not recommended.

Scope

- Overview of Colorectal Cancer, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on Cyramza including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for Cyramza for the top seven countries from 2013 to 2023.
- Sales information covered for the US, France, Germany, Italy, Spain, the UK and Japan.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of the competition by understanding the changing competitive landscape for Colorectal Cancer
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of Cyramza performance
- Obtain sales forecast for Cyramza from 2013-2023 in top seven countries (the US, France, Germany, Italy, Spain, the UK and Japan)

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 10
2.3 Upcoming Related Reports 11
3 Disease Overview 12
3.1 Etiology and Pathophysiology 12
3.1.1 Etiology 12
3.1.2 Pathophysiology 14
3.2 Clinical Staging 15
3.3 Symptoms 16
4 Disease Management 18

1.1 List of Tables
Table 1: TNM and Staging Classification System for CRC 16
Table 2: Symptoms of Colorectal Cancer 17
Table 3: Treatment Guidelines for CRC 22
Table 4: Most-Prescribed Neoadjuvant/Adjuvant Regimens for Early-Stage CRC in the Global Markets, 2013 23
Table 5: Most Prescribed Targeted Therapies for Metastatic CRC by Segment in the Global Markets, 2013 24
Table 6: Leading Treatments for CRC, 2014 33
Table 7: Unmet Need and Opportunity in CRC 35
Table 8: Product Profile - Cyramza 50
Table 9: Cyramza SWOT Analysis, 2014 53
Table 10: Global Sales Forecasts ($m) for Cyramza, 2013-2023 54
Table 11: Average Body Weight and Surface Area Across the 8MM 66
Table 12: High-Prescribing Physicians (non-KOLs) Surveyed, By Country 68

To Browse a Full Report with Toc: http://www.researchmoz.us/cyramza-colorectal-cancer-forecast-and-market-analysis-to-2023-report.html

All Reports of this Category Here: http://www.researchmoz.us/pharmaceutical-market-reports-38.html

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Contact US:


For More Information Kindly Contact:
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://mresearchreports.blogspot.com/http://mresearchreports.blogspot.com/
Get More Market Research Report : https://www.linkedin.com/today/author/355409463

Global Imprime PGG (Colorectal Cancer) - Forecast and Market Analysis to 2023

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

Summary

GlobalData has released its new PharmaPoint Drug Evaluation report, Imprime PGG (Colorectal Cancer) - Forecast and Market Analysis to 2023. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus represents a huge burden on healthcare systems.

To Browse a Full Report with Toc: http://www.researchmoz.us/imprime-pgg-colorectal-cancer-forecast-and-market-analysis-to-2023-report.html

This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the colorectal cancer market, with coverage of multiple settings of the disease including neoadjuvant/adjuvant, first-, second-, third-line KRAS wild-type and mutation-positive, and fourth-line metastatic. In terms of targeted treatments, the metastatic CRC treatment landscape is mature, including the branded treatments Avastin (bevacizumab), Erbitux (cetuximab), and Vectibix (panitumumab), treatments that have extended the survival of metastatic patients compared to chemotherapy-only regimens. However, high unmet needs remain for the extension of survival of metastatic patients, and particularly those with KRAS mutation-positive disease, for whom the epidermal growth factor receptor (EGFR) inhibitors Erbitux and Vectibix are not recommended.

Scope

- Overview of Colorectal Cancer, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on Imprime PGG including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for Imprime PGG for the top six countries from 2013 to 2023.
- Sales information covered for the US, France, Germany, Italy, Spain and the UK.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of the competition by understanding the changing competitive landscape for Colorectal Cancer
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of Imprime PGG performance
- Obtain sales forecast for Imprime PGG from 2013-2023 in top six countries (the US, France, Germany, Italy, Spain and the UK)

 1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 10
2.3 Upcoming Related Reports 11
3 Disease Overview 12
3.1 Etiology and Pathophysiology 12
3.1.1 Etiology 12
3.1.2 Pathophysiology 14
3.2 Clinical Staging 15
3.3 Symptoms 16
4 Disease Management 18

1.1 List of Tables
Table 1: TNM and Staging Classification System for CRC 16
Table 2: Symptoms of Colorectal Cancer 17
Table 3: Treatment Guidelines for CRC 22
Table 4: Most-Prescribed Neoadjuvant/Adjuvant Regimens for Early-Stage CRC in the Global Markets, 2013 23
Table 5: Most Prescribed Targeted Therapies for Metastatic CRC by Segment in the Global Markets, 2013 24
Table 6: Leading Treatments for CRC, 2014 33
Table 7: Unmet Need and Opportunity in CRC 35
Table 8: Product Profile - Imprime PGG 49
Table 9: Imprime PGG SWOT Analysis, 2014 52
Table 10: Global Sales Forecasts ($m) for Imprime PGG, 2013-2023 53
Table 11: Average Body Weight and Surface Area Across the 8MM 65
Table 12: High-Prescribing Physicians (non-KOLs) Surveyed, By Country 67

To Browse a Full Report with Toc: http://www.researchmoz.us/imprime-pgg-colorectal-cancer-forecast-and-market-analysis-to-2023-report.html

All Reports of this Category Here: http://www.researchmoz.us/pharmaceutical-market-reports-38.html


About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Contact US:


For More Information Kindly Contact:
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://mresearchreports.blogspot.com/
Get More Market Research Report : https://www.linkedin.com/today/author/355409463